Metropolitan Life Insurance Company (MetLife)’s Verastem VSTM Stock Holding History
Bought
Maintained
Sold
Other funds holding VSTM
BBA
BI
EAM
MB
ACM
Metropolitan Life Insurance Company (MetLife)'s VSTM Position: Q2 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Verastem (VSTM) in Q2 2022, closing a stake of 1,017 shares — an estimated $17.2K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in VSTM in Q2 2013 and held it in 17 quarters. The position peaked at $246K in Q1 2015. 122 funds tracked by Wall St. Rank hold VSTM as of Q2 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Verastem position as of Q2 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,017 Verastem shares in Q2 2022, an estimated $17.2K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Verastem in Q2 2013 and held it in 17 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Verastem position peaked at $246K in Q1 2015.
- 122 funds tracked by Wall St. Rank held Verastem as of Q2 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.